Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2026) 117 EP11 | DOI: 10.1530/endoabs.117.EP11

SFEBES2026 ePoster Presentations Metabolism, Obesity and Diabetes (5 abstracts)

Assessment of the antidiabetic potential of portulaca oleracea extract in a cadmium chloride–induced rat model: targeting insulin sensitivity, dyslipidemia, and oxidative stress pathways

Nahed Alharthi


Prince Sattam Bin Abdulaziz University, Riyadh- Alkharj, Saudi Arabia


Environmental toxins like cadmium chloride (CdCl2) are implicated in T2D pathogenesis by promoting oxidative stress and impairing insulin signaling. Portulaca oleracea (Purslane), a traditional medicinal plant, is rich in antioxidants and omega-3 fatty acids, suggesting potential antidiabetic properties. However, its efficacy against heavy metal-induced T2D and the comparative potency of its different extracts remain poorly elucidated. This study aimed to investigate and compare the therapeutic effects of purslane aqueous extract (PAE) and purslane hydroalcoholic extract (PHE) on a CdCl2-induced rat model of T2D, focusing on glycemic control, insulin sensitivity, lipid metabolism, and antioxidant activity.Thirty-five male Sprague-Dawley rats were divided into five groups: a normal control, a CdCl2-induced diabetic control (1 mg/kg/i.p., daily), a positive control treated with metformin, and two treatment groups receiving either PAE or PHE (400 mg/kg/p.o. each) for four weeks alongside CdCl2. Fasting blood glucose (FBG) and body weight were monitored weekly. An oral glucose tolerance test (OGTT) was conducted at the end of the study. Serum was analyzed for insulin, adiponectin, leptin, alpha-amylase, alpha-glucosidase, and lipid profile. Homeostatic model assessment for insulin resistance (HOMA-IR) was calculated. Oxidative stress markers were measured in hepatic and pancreatic tissues, followed by histopathological examination.Thirty-five male Sprague-Dawley rats were divided into five groups: a normal control, a CdCl2-induced diabetic control, a positive control treated with metformin, and two treatment groups receiving either PAE or PHE (400 mg/kg/p.o. each) for four weeks alongside CdCl2. Fasting blood glucose (FBG) and body weight were monitored weekly. An oral glucose tolerance test (OGTT) was conducted at the end of the study. Serum was analyzed for insulin, adiponectin, leptin, alpha-amylase, alpha-glucosidase, and lipid profile. Homeostatic model assessment for insulin resistance (HOMA-IR) was calculated. Oxidative stress markers were measured in hepatic and pancreatic tissues, followed by histopathological examination.

Volume 117

Society for Endocrinology BES 2026

Harrogate, United Kingdom
02 Mar 2026 - 04 Mar 2026

Society for Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches